STATEMENT 2022

Ferring Statement on Minirin® / Octostim® / DDAVP® / Stimate® (desmopressin) Nasal Spray

By celia in STATEMENT 2025, STATEMENT 2022 on 21 June 2022

Following the detection of out-of-specification results during testing, in 2020 Ferring initiated a precautionary voluntary global recall of all batches of the following products: Minirin® (desmopressin) Nasal Spray 0.1 mg/ml…

Ferring statement on the Ukraine crisis

By celia in STATEMENT 2022 on 10 March 2022

As we witness the escalating humanitarian crisis caused by the war in Ukraine, Ferring continues to stand by the people impacted and support those in need. As a healthcare company with a purpose to build families and help people live better lives, we are supporting three major emergency relief efforts…

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.